NCT06405217
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment treatment Not Available recruiting NCT05007093
Study on the Treatment of Differentiated Thyroid Carcinoma With Anlotinib treatment 2 active_not_recruiting NCT02966093
A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China treatment 3 completed NCT02041260
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting treatment 2 unknown_status NCT02432274
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma treatment 1 / 2 completed NCT01788982
Nintedanib(BIBF1120) in Thyroid Cancer treatment 2 completed NCT06647602
Thyroid Hormone for Thyroid Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT06235216
Sacituzumab govitEcan in THYroid Cancers treatment 2 recruiting NCT04940052
Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer treatment 3 active_not_recruiting NCT03794375
Primary Care Transfer for Thyroid Cancer Patients No drug interventions other Not Available active_not_recruiting NCT05660954
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. treatment 2 active_not_recruiting NCT05024929
Targeted Therapy to Increase RAI Uptake in Metastatic DTC No drug interventions Not Available Not Available recruiting NCT05783323
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer treatment 2 recruiting NCT06458036
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) treatment 2 not_yet_recruiting NCT04964284
Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer treatment 3 recruiting NCT01876784
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer treatment 3 completed NCT04321954
Lenvatinib in Locally Advanced Invasive Thyroid Cancer treatment 2 recruiting NCT05078853
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma No drug interventions Not Available Not Available recruiting NCT04137185
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients treatment 1 / 2 completed NCT02586337
Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) treatment 2 / 3 unknown_status NCT01700699
Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors No drug interventions Not Available Not Available unknown_status NCT05745363
Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer No drug interventions treatment 1 / 2 recruiting NCT00295763
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. treatment 3 completed NCT05604963
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers No drug interventions treatment Not Available recruiting NCT05599139
Iodine Uptake After a Low Iodine Diet No drug interventions treatment Not Available recruiting NCT02211222
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer Not Available Not Available approved_for_marketing NCT05989425
Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer treatment 2 recruiting NCT03630120
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer treatment 2 terminated NCT04971473
Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal treatment 3 completed NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT04563780
The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer No drug interventions Not Available Not Available unknown_status NCT03602495
A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer treatment 3 terminated NCT03191643
PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer No drug interventions Not Available Not Available completed NCT01641679
PET Evaluation of Recurrent Differentiated Thyroid Cancer No drug interventions Not Available Not Available unknown_status NCT01263951
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone treatment 2 unknown_status NCT03048877
Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer treatment 3 active_not_recruiting NCT02638077
Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China No drug interventions Not Available Not Available unknown_status NCT04880798
Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer No drug interventions diagnostic Not Available unknown_status NCT05014698
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT02278198
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123 diagnostic 1 completed NCT04447183
The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer. treatment 2 active_not_recruiting NCT00668811
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer treatment 2 completed NCT03690388
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy treatment 3 active_not_recruiting NCT03176485
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors No drug interventions prevention Not Available completed NCT03757637
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients No drug interventions supportive_care Not Available recruiting NCT03986437
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection. No drug interventions Not Available Not Available completed NCT02244463
A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer treatment 1 / 2 completed NCT06154863
Recurrence in Patients With Differentiated Thyroid Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03416686
Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy No drug interventions treatment Not Available unknown_status NCT04857086
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China No drug interventions Not Available Not Available unknown_status NCT02304757
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis treatment Not Available completed NCT01586520
Diagnosing Thyroid Cancer Using a Blood Test No drug interventions Not Available Not Available completed NCT01843062
Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer treatment 3 terminated NCT04391244
Investigating National Solutions for Personalised Iodine-131 Radiation Exposure No drug interventions Not Available Not Available recruiting NCT05789667
Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer Not Available Not Available recruiting NCT04858867
Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET) No drug interventions treatment Not Available recruiting NCT02870569
Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer treatment 2 completed NCT05852223
Pembrolizumab in High-risk Thyroid Cancer treatment 2 not_yet_recruiting NCT03002623
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer treatment 2 terminated